profession

MRSA surgical infections exact heavy clinical, financial toll

Preventing the resistant staph infection could lower readmission and mortality rates and save hospitals thousands in costs associated with caring for readmitted patients.

By — Posted Jan. 14, 2010

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

Methicillin-resistant Staphylococcus aureus, the hard-to-control superbug, wreaks havoc on the surgical patients who contract it and is a financial burden for hospitals, new research shows.

Compared with patients who go home from surgery uninfected, patients with MRSA infections are 35 times more likely to be readmitted to the hospital and seven times more likely to die within three months, according to a study in the December 2009 PLoS ONE (link). PLoS ONE is a multidisciplinary, peer-reviewed journal published by the nonprofit Public Library of Science.

The study also found that patients infected with MRSA after surgery spent an additional three weeks in the hospital and cost $60,000 more to care for.

"My experience as a doctor for over 30 years is that these infections, once they develop, are just terribly hard to get rid of," said Daniel J. Sexton, MD, senior author of the study. "When you add the time -- every day in the hospital is extraordinarily expensive, and so is every readmission -- you do the simple arithmetic on that, and you get a big number."

Dr. Sexton and his colleagues studied outcomes for 659 surgical patients at one tertiary care center and six community hospitals affiliated with the Duke Infection Control Outreach Network, a collaboration of Duke University School of Medicine in North Carolina and 35 hospitals nationwide. Dr. Sexton directs the network.

Of the 150 patients who contracted MRSA surgical infections, 25 died within 90 days and 110 were readmitted. The median hospital charge was nearly $80,000. Dr. Sexton said the clinical and cost effectiveness of preventive measures such as screening high-risk patients for MRSA colonization before surgery is unclear. But, he added, understanding the costs of inaction is key to saving money and protecting patients.

"We constantly encounter people who say we can't afford this or we can't afford that -- it's too expensive," said Dr. Sexton, an infectious disease specialist and professor of medicine at Duke. "The missing part of the equation is what's the expense of not doing anything. ... People have got to set their priorities and look at their resources, but just accepting the status quo can lose a lot of money and hurt a lot of patients."

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story